Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Buy
53
AFRM Quote, Financials, Valuation and Earnings
Last price:
$49.74
Seasonality move
:
3.4%
Day range:
$49.57 - $52.99
52-week range:
$22.25 - $82.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.81x
P/B ratio:
5.75x
Volume:
7.4M
Avg. volume:
8M
1-year change:
50.81%
Market cap:
$16B
Revenue:
$2.3B
EPS (TTM):
-$0.65
Analysts' Opinion
-
Consensus RatingAffirm Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $68.09, Affirm Holdings has an estimated upside of 35.1% from its current price of $50.40.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $45.00 representing 100% downside risk from its current price of $50.40.
Fair Value
-
According to the consensus of 18 analysts, Affirm Holdings has 35.1% upside to fair value with a price target of $68.09 per share.
AFRM vs. S&P 500
-
Over the past 5 trading days, Affirm Holdings has overperformed the S&P 500 by 13.44% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Affirm Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Affirm Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Affirm Holdings reported revenues of $866.4M.
Earnings Growth
-
Affirm Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Affirm Holdings reported earnings per share of $0.23.
Enterprise value:
21.6B
EV / Invested capital:
--
Price / LTM sales:
5.81x
EV / EBIT:
105.51x
EV / Revenue:
7.72x
PEG ratio (5yr expected):
-0.47x
EV / Free cash flow:
35.28x
Price / Operating cash flow:
26.55x
Enterprise value / EBITDA:
52.88x
Gross Profit (TTM):
$1.9B
Return On Assets:
-2.06%
Net Income Margin (TTM):
-7.1%
Return On Equity:
-7.31%
Return On Invested Capital:
-2.1%
Operating Margin:
11.95%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $1.5B | $1.9B | $2.8B | $591.1M | $866.4M | |
| Gross Profit | $721.1M | $1B | $1.9B | $381.1M | $602.2M | |
| Operating Income | -$1B | -$625.1M | $31.3M | -$87.5M | $103.5M | |
| EBITDA | -$656.2M | -$322M | $409M | -$56.5M | $245.5M | |
| Diluted EPS | -$2.80 | -$2.49 | -$0.65 | -$0.54 | $0.23 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.5B | $5.8B | $6.5B | $7.7B | $9.1B | |
| Total Assets | $2.7B | $7B | $7.8B | $9.1B | $10.5B | |
| Current Liabilities | $74M | $102.9M | $93.8M | $135.4M | $150.2M | |
| Total Liabilities | $3.1B | $4.5B | $5.3B | $6.4B | $7.7B | |
| Total Equity | -$349.6M | $2.5B | $2.5B | $2.6B | $2.8B | |
| Total Debt | $1.7B | $4B | $5B | $6.2B | $7.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$64.4M | $162.7M | $785.8M | $74.3M | $312M | |
| Cash From Investing | -$1.8B | -$1.7B | -$1.3B | -$624.9M | -$89.1M | |
| Cash From Financing | $896.3M | $1.1B | $867.7M | $506.3M | $144.1M | |
| Free Cash Flow | -$203.4M | $32.8M | $613M | $35.6M | $268.1M | |
AFRM
Sector
Market Cap
$16B
$603.7M
Price % of 52-Week High
61.07%
84.45%
Dividend Yield
0%
2.05%
Shareholder Yield
--
3.98%
1-Year Price Total Return
50.81%
9.07%
Beta (5-Year)
--
0.555
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$46.28
200-day SMA
Buy
Level
$48.98
Bollinger Bands (100)
Sell
Level
46.6 - 69.22
Chaikin Money Flow
Buy
Level
262.9M
20-day SMA
Buy
Level
$43.04
Relative Strength Index (RSI14)
Buy
Level
58.35
ADX Line
Buy
Level
20.25
Williams %R
Sell
Level
-15.7161
50-day SMA
Sell
Level
$51.56
MACD (12, 26)
Sell
Level
-0.20
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
540.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5772)
Sell
CA Score
(Annual)
Level (-1.3776)
Buy
Beneish M-Score
(Annual)
Level (-2.5398)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (0.5244)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
Stock Forecast FAQ
In the current month, AFRM has received 10 Buy ratings 8 Hold ratings, and 0 Sell ratings. The AFRM average analyst price target in the past 3 months is $68.09.
-
Where Will Affirm Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Affirm Holdings share price will rise to $68.09 per share over the next 12 months.
-
What Do Analysts Say About Affirm Holdings?
Analysts are divided on their view about Affirm Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Affirm Holdings is a Sell and believe this share price will drop from its current level to $45.00.
-
What Is Affirm Holdings's Price Target?
The price target for Affirm Holdings over the next 1-year time period is forecast to be $68.09 according to 18 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is AFRM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Affirm Holdings is a Buy. 10 of 18 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of AFRM?
You can purchase shares of Affirm Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Affirm Holdings shares.
-
What Is The Affirm Holdings Share Price Today?
Affirm Holdings was last trading at $49.74 per share. This represents the most recent stock quote for Affirm Holdings. Yesterday, Affirm Holdings closed at $50.40 per share.
-
How To Buy Affirm Holdings Stock Online?
In order to purchase Affirm Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
